Shanghai United Imaging Healthcare Co., Ltd. (SHA:688271)
China · Delayed Price · Currency is CNY 148.30
+1.07 (0.73%)
Last updated: Sep 25, 2025, 11:26 AM CST
SHA:688271 Revenue
Shanghai United Imaging Healthcare had revenue of 3.54B CNY in the quarter ending June 30, 2025, with 18.60% growth. This brings the company's revenue in the last twelve months to 10.98B, down -4.27% year-over-year. In the year 2024, Shanghai United Imaging Healthcare had annual revenue of 10.30B, down -9.73%.
Revenue (ttm)
10.98B
Revenue Growth
-4.27%
P/S Ratio
10.99
Revenue / Employee
1.30M
Employees
8,173
Market Cap
120.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.30B | -1.11B | -9.73% |
| Dec 31, 2023 | 11.41B | 2.17B | 23.52% |
| Dec 31, 2022 | 9.24B | 1.98B | 27.36% |
| Dec 31, 2021 | 7.25B | 1.49B | 25.91% |
| Dec 31, 2020 | 5.76B | 2.78B | 93.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |